US Alcohol-Attributable Cancer Deaths Doubled From 1990 to 2023
Annual alcohol-attributable cancer deaths in the United States doubled from 11,361 in 1990 to 23,126 in 2023, according to a study published in The Lancet Regional Health—Americas and initially presented at the American Society of Clinical Oncology Annual Meeting. Researchers at the Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, utilized more than three decades of Global Burden of Disease data to track mortality shifts across diverse demographic groups and cancer classifications.
- Mortality Surge: Annual U.S. cancer deaths directly linked to alcohol consumption rose from 11,361 in 1990 to 23,126 in 2023.
- Demographic Shift: Men and adults aged 55 and older experienced the highest total mortality burden, though striking trends emerged among younger cohorts.
- Broad Carcinogenic Impact: While liver cancer remains heavily associated with alcohol, breast cancer led among women and colorectal cancer became a leading cause of death among younger adults.
Epidemiological Shifts Across Three Decades
The longitudinal investigation demonstrates that the public health impact of alcohol extends well beyond liver malignancies. Alcohol is classified as a Group 1 carcinogen by the International Agency for Research on Cancer, putting it in the same risk category as tobacco smoke and asbestos. Despite this biological categorization, public awareness of alcohol as a modifiable risk factor for various malignancies remains low compared to tobacco awareness.
According to corresponding author Chinmay Jani, chief fellow in hematology and oncology at Sylvester Comprehensive Cancer Center, the breadth of alcohol’s impact across multiple organ systems surprised the research team. While the relationship with hepatic cancer is well-documented, public understanding of its contribution to colorectal, esophageal, breast, pancreatic, and prostate cancers lags behind clinical evidence.
Demographic and Geographic Mortality Patterns
The analysis revealed distinct vulnerabilities when stratifying the data by age and biological sex. Among older men, liver cancer accounted for the highest alcohol-attributable mortality rates, followed by esophageal and colorectal cancers. Among women, breast cancer represented the primary source of alcohol-attributable cancer mortality.
From Instagram — related to alcohol attributable cancer deaths, Sylvester Comprehensive Cancer Center study
A concerning epidemiological pattern emerged in younger demographics. For men aged 20 to 54, colorectal cancer surfaced as the leading alcohol-attributable cause of cancer death. Among women in that same 20-to-54 age bracket, breast cancer ranked first, followed by colorectal cancer.
Geographically, mortality rates varied significantly across states and territories. In 2023, Washington, D.C., recorded the highest alcohol-attributable cancer mortality rates, whereas Utah recorded the lowest. Researchers noted that these findings hold particular relevance for states like Florida, which maintains a substantial population of older adults—the exact age cohort experiencing the highest mortality burden.
Clinical Implications and Preventive Oncology
Senior author Gilberto Lopes, chief of the division of medical oncology at the Miller School, emphasized that the data reinforces the necessity of transparent clinical communication regarding modifiable lifestyle risks. Patients seeking comprehensive risk assessments can consult with specialized oncology and preventive care clinics to evaluate personal risk factors and establish proactive screening schedules.
“What this study makes clear is that alcohol-related cancer risk is not limited to one disease or one group of people,” Lopes stated. He noted that framing alcohol as a modifiable risk factor allows clinicians to guide patients toward lifestyle modifications that reduce overall oncologic morbidity.
While the exact threshold for a safe dose of alcohol remains under investigation, the findings suggest that minimizing consumption toward the lowest amount feasible for each individual can help mitigate long-term risk. For individuals navigating complex family histories of malignancy or seeking personalized diagnostic evaluations, scheduling a consultation through accredited diagnostic centers remains a critical component of standard preventative care.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.